Publicaciones en las que colabora con AITOR ECHEVARRIA GALLEGO (21)

2024

  1. Serological Antibodies against Kidney, Liver, and Spleen Membrane Antigens as Potential Biomarkers in Patients with Immune Disorders

    International Journal of Molecular Sciences, Vol. 25, Núm. 4

2017

  1. Analysis of LDLR variants from homozygous FH patients carrying multiple mutations in the LDLR gene

    Atherosclerosis, Vol. 263, pp. 163-170

  2. Identification and in vitro characterization of two new PCSK9 Gain of Function variants found in patients with Familial Hypercholesterolemia

    Scientific Reports, Vol. 7, Núm. 1

2016

  1. Structural changes induced by acidic pH in human apolipoprotein B-100

    Scientific Reports, Vol. 6

  2. The p.Leu167del mutation in APOE gene causes autosomal dominant hypercholesterolemia by down-regulation of LDL receptor expression in hepatocytes

    Journal of Clinical Endocrinology and Metabolism, Vol. 101, Núm. 5, pp. 2113-2121

2015

  1. Activity-associated effect of LDL receptor missense variants located in the cysteine-rich repeats

    Atherosclerosis, Vol. 238, Núm. 2, pp. 304-312

  2. Adenilato ziklasa toxinak bakterioen barneratzea eragiten du zelula ez-fagozitikoetan

    I. IkergazteNazioarteko ikerketa euskaraz. Kongresuko artikulu-bilduma: 2015eko maiatzaren 13, 14 eta 15a. Durango, Euskal Herria

  3. Adenylate Cyclase Toxin promotes bacterial internalisation into non phagocytic cells

    Scientific Reports, Vol. 5

  4. Characterization of the First PCSK9 Gain of Function Homozygote

    Journal of the American College of Cardiology

  5. Functional characterization and classification of frequent low-density lipoprotein receptor variants

    Human Mutation, Vol. 36, Núm. 1, pp. 129-141

  6. Hiperkolesterolemia familiarra: LDLR, APOB eta PCSK9-en mutazioen balioztapen funtzionala diagnostiko zehatz baterako.

    I. IkergazteNazioarteko ikerketa euskaraz. Kongresuko artikulu-bilduma: 2015eko maiatzaren 13, 14 eta 15a. Durango, Euskal Herria

  7. Structural analysis of APOB variants, p.(Arg3527Gln), p.(Arg1164Thr) and p.(Gln4494del), causing Familial Hypercholesterolaemia provides novel insights into variant pathogenicity

    Scientific Reports, Vol. 5

  8. The importance of an integrated analysis of clinical, molecular, and functional data for the genetic diagnosis of familial hypercholesterolemia

    Genetics in Medicine, Vol. 17, Núm. 12, pp. 980-988

2014

  1. Advantages and versatility of fluorescence-based methodology to characterize the functionality of LDLR and class mutation assignment

    PLoS ONE, Vol. 9, Núm. 11

  2. Novel functional APOB mutations outside LDL-binding region causing familial hypercholesterolaemia

    Human Molecular Genetics, Vol. 23, Núm. 7, pp. 1817-1828

2013

  1. Ca2+ Influx and Tyrosine Kinases Trigger Bordetella Adenylate Cyclase Toxin (ACT) Endocytosis. Cell Physiology and Expression of the CD11b/CD18 Integrin Major Determinants of the Entry Route

    PLoS ONE, Vol. 8, Núm. 9

  2. Calpain-Mediated Processing of Adenylate Cyclase Toxin Generates a Cytosolic Soluble Catalytically Active N-Terminal Domain

    PLoS ONE, Vol. 8, Núm. 6

2012

  1. Functional characterization of splicing and ligand-binding domain variants in the LDL receptor

    Human Mutation, Vol. 33, Núm. 1, pp. 232-243

2009

  1. Endophilin B1/Bif-1 stimulates BAX activation independently from its capacity to produce large scale membrane morphological rearrangements

    Journal of Biological Chemistry, Vol. 284, Núm. 7, pp. 4200-4212

2008

  1. BIM and tBID are not mechanistically equivalent when assisting BAX to permeabilize bilayer membranes

    Journal of Biological Chemistry, Vol. 283, Núm. 12, pp. 7790-7803